These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 890699)

  • 21. [Antitumor antibiotics of the anthracycline series and their semisynthetic derivatives].
    Povarov LS
    Antibiotiki; 1977 Jul; 22(7):653-67. PubMed ID: 883809
    [No Abstract]   [Full Text] [Related]  

  • 22. Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin.
    Frederick CA; Williams LD; Ughetto G; van der Marel GA; van Boom JH; Rich A; Wang AH
    Biochemistry; 1990 Mar; 29(10):2538-49. PubMed ID: 2334681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicin.
    Ando S; Kamiya K; Yoshimura T; Tsutani H; Ueda T; Uchida M; Nakamura T; Uchino H
    Anticancer Res; 1988; 8(3):409-15. PubMed ID: 3164610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract]   [Full Text] [Related]  

  • 25. A theoretical study of the comparative binding affinities of daunomycin derivatives to a double-stranded oligomeric DNA. Proposal for new high affinity derivatives.
    Chen KX; Gresh N; Pullman B
    Mol Pharmacol; 1986 Sep; 30(3):279-86. PubMed ID: 3748009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthracycline mechanisms in analogue selection.
    Acton EM
    Drugs Exp Clin Res; 1985; 11(1):1-8. PubMed ID: 3915272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics.
    Studzian K; Wasowska M; Piestrzeniewicz MK; Wilmańska D; Szmigiero L; Oszczapowicz I; Gniazdowski M
    Neoplasma; 2001; 48(5):412-8. PubMed ID: 11845988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-cancer activity of anthracycline antibiotics and DNA condensation.
    Cera C; Palumbo M
    Anticancer Drug Des; 1990 Aug; 5(3):265-71. PubMed ID: 2400539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adriamycin and related anthracycline antibiotics.
    Brown JR
    Prog Med Chem; 1978; 15():125-64. PubMed ID: 400611
    [No Abstract]   [Full Text] [Related]  

  • 30. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular distribution and intracellular dynamics of a spin-labeled analogue of doxorubicin fluorescence and EPR spectroscopy.
    Rapoport N; Pitina L
    J Pharm Sci; 1998 Mar; 87(3):321-5. PubMed ID: 9523985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of daunorubicin and doxorubicin with DNA and chromatin.
    Zunino F; Di Marco A; Zaccara A; Gambetta RA
    Biochim Biophys Acta; 1980 Apr; 607(2):206-14. PubMed ID: 7370266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.
    Arcamone F
    Cancer Res; 1985 Dec; 45(12 Pt 1):5995-9. PubMed ID: 3864526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid.
    Graves DE; Krugh TR
    Biochemistry; 1983 Aug; 22(16):3941-7. PubMed ID: 6615810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLC--mass spectrometry of several important anticancer drugs II: doxorubicin and daunorubicin aglycone analogs.
    Chan KK; Watson E
    J Pharm Sci; 1978 Dec; 67(12):1748-52. PubMed ID: 722494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymatic activation and binding of adriamycin to nuclear DNA.
    Sinha BK; Trush MA; Kennedy KA; Mimnaugh EG
    Cancer Res; 1984 Jul; 44(7):2892-6. PubMed ID: 6327028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.
    Arcamone F; Bernardi L; Patelli B; Giardino P; Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Experientia; 1978 Oct; 34(10):1255-7. PubMed ID: 570116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.
    Skovsgaard T
    Biochem Pharmacol; 1977 Feb; 26(3):215-22. PubMed ID: 14644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.